Trilogy International Partners Inc (TSE:TRL) has been assigned a C$10.50 target price by equities researchers at TD Securities in a research report issued on Friday. The brokerage presently has a “buy” rating on the specialty pharmaceutical company’s stock. TD Securities’ price target would suggest a potential upside of 34.62% from the stock’s current price.

Separately, Scotiabank reaffirmed an “outperform” rating and set a C$13.00 price target on shares of Trilogy International Partners in a research report on Monday, May 15th.

Trilogy International Partners (TSE:TRL) remained flat at $7.80 on Friday. The company’s stock had a trading volume of 700 shares. Trilogy International Partners has a 12-month low of $7.54 and a 12-month high of $10.48. The stock has a 50-day moving average of $8.37 and a 200-day moving average of $9.34. The stock’s market capitalization is $331.60 million.

TRADEMARK VIOLATION WARNING: This news story was published by Daily Political and is owned by of Daily Political. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at

About Trilogy International Partners

Trilogy International Partners Inc, formerly Alignvest Acquisition Corporation, is a Canada-based wireless telecommunications operator. The Company provides wireless communications services through its subsidiaries in New Zealand and Bolivia. Its subsidiaries include Viva and 2degrees. Viva provides voice and a range of data services to its mobile customers over its third generation (3G)-enabled global system for mobile communications (GSM) and fourth generation (4G) long term evolution (LTE) networks.

Receive News & Ratings for Trilogy International Partners Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy International Partners Inc and related companies with's FREE daily email newsletter.